SlideShare a Scribd company logo
Richard
Bierney
1. To review general requirements for documents
2. To review specific requirements for each
document
3. To consider current issues applicable to a
facility
Good documentation is an essential part of the
QA
system
Should exist for all aspects of
GMP Purpose of documentation
 Defines specifications and
procedures for all
materials and methods of
manufacture and control
 Ensures all personnel know what to do and when
to do it
 Ensures that authorized persons have all
information necessary for release of product
Purpose of documentation (cont.)
 Ensures documented evidence, traceability and
provides records and audit trail for
investigation
 Ensures availability of data for validation, review
and statistical analysis
Design and use
 Depends upon manufacturer
 Some documents combined into one, sometimes
separate
Documents should be
 Designed
 Prepared
 Reviewed
 Distributed
with care
Carefully controlled
Comply with Marketing
Authorization
Design of documentation
important Look at the “Style” of
the document
 Instructions in the imperative
 Short sentences preferred to
long sentences
Approval of documentation
 Approved, signed and dated by appropriate
responsible persons
 No document should be changed without
authorization and approval
Contents of documents should be clear (easy
to understand) and include, e.g.
 Title, nature, objective or purpose
Layout in orderly fashion
Easy to be filled in and checked
Clear and readable – including copies made
No errors if master documents are copied
for working documents
Documentation control
Regular review of documents
Kept up to date (current) - amended
Superseded documents removed and not
used
 Distribution and retrieval of documentation
Retention time for superseded documents
Data entry
Clear, readable and indelible
Design to allow for sufficient space for
entries Changes to entries:
 signed, dated and reason given
 original entry still readable
Entries at the time of action
All significant actions recorded – traceable
Data entry
(cont.)
Electronic data processing systems,
photographic
systems or other reliable means
 Systems require SOPs and records
 Accuracy of records checked
 Authorized persons - access and changes
 Password controlled
 Entries checked
Data entry (cont.)
Batch records stored electronically:
 Protected
 Back-up transfer, e.g. magnetic tape, microfilm,
paper print-outs
Records kept 1 year after expiry date of
product Data readily available during
retention period
Labels
Specifications and testing procedures
Master formulae and instructions
Batch processing and batch packaging
records Standard Operating Procedures
(SOPs) Records
 Stock control and distribution records
Other documents …
Photographs
can be
documents
provided they
are properly
authorised
and
controlled
Flow charts provide substantial information
at a glance
What must be labelled?
• Containers, equipment, premises
• Intermediates and bulk products
Label information?
•Clear, unambiguous, company format
Colours can be used, e.g. green
(accepted), red (rejected)
Different types of
labels,
e.g. cleaning status,
production stage,
status of materials
Other types of labels?
Labels can indicate
the status of
materials such as
"quarantine"
National legislation, but
includes: Name
Active ingredients and amounts
Batch number
Expiry date
Storage conditions, precautions if
necessary Directions for use, warnings
Name and address of manufacturer
Label to include:
Name
Potency or
concentration Date of
manufacture
Expiry date
Date the closure is first
opened Storage condition
Control number
Authorized, approved, signed and dated
 Starting, packaging materials and finished products:
include tests on identity, content, purity, quality
 Intermediates and bulk
 Water, solvents and reagents
QC, QA or documentation centre
• Documented Specifications Are required
for
• Starting and packaging materials
• Finished products
Specifications:
Periodic review
Compliance with current pharmacopoeia
Pharmacopoeia, reference standards and
spectra available
Test Procedures:
Validated (facility and equipment) before
routinely used
Master formula for each product and batch
size Manufacturing instructions include:
 Name of product with product
reference code
 Dosage form, strength and batch size
 List of starting materials including quantities and
unique reference code
 Expected final yield with acceptable limits (and
intermediate yields)
 Processing location and principal equipment
Manufacturing instructions – continued
 Equipment preparation (e.g. cleaning, assembling,
calibrating, etc.)
 Detailed stepwise processing instructions and
checks, pre-treatments, sequence of
additions, times, temperatures, etc.
 In-process control instructions and their limits
 Storage requirements and special precautions
 Any special precautions if needed
Authorized packing instructions for each
product, pack size and type, and to include:
 Name of the product
 Dosage form, strength and method of
application
 Pack size (number, weight or volume of product in
final container)
 List of all packaging materials (quantities, size,
types and code number)
Packing instructions – continued
 Examples of printed packaging materials, with
location of batching information
 Special precautions, including area clearance
checks (before and after operations)
 Description of the packaging operation including
equipment to be used
 In-process controls, with sampling instructions and
acceptance limits
Record kept for each batch processed
Based on the master or specifications
(e.g. copied to avoid errors)
Check suitability of area and equipment
 clear of previous products, documents,
materials
Checks recorded
Information recorded during processing
include: Name of the product, batch
number
Dates and times (e.g. start, major steps,
completion)
Name of person responsible for each stage
of production
Name of operators carrying out each step
(check signatures)
Theoretical quantities for materials in the batch
Reference number and quantity of materials used
in the batch
Main processing steps and key equipment
In-process controls carried out, person's initials,
and results obtained
Yield at each stage with comments on
deviations Expected final yield with
acceptable limits Comments on any
deviations from process
Area clearance check, instructions to
operators Record of activities
For every batch or part of a batch
Based on approved packaging instructions,
copied
or computer generated
Before start – checks that equipment and
work station suitable and clean, no
previous product
Line clearance
(opening) Recorded
Name of the product, batch number and
quantity to be packed
Batch number, theoretical quantity and
actual quantity of finished product
Actual quantity obtained –
reconciliation Dates and times of
operation
Name of person responsible for packaging,
initials of operators carrying out each step
Checks, and in-process results
Details of packaging operation, including
equipment and line used
Returns to store
Specimen of printed packaging materials, with
batch coding approval (batch number and expiry
date) Comments on deviations from the process
and actions taken and authorization
Reconciliation of packaging materials, including
issues, use, returns and destruction
What is an SOP?
Who is responsible for preparing
SOPs?
What is the format for an SOP?
Which activities require SOPs?
Where should SOPs be stored?
Are SOPs associated with
records?
Which activities require SOPs?
Equipment and analytical apparatus:
– Assembly, validation
– Calibration
– Internal labelling, quarantine and storage of
materials
– Operation
– Maintenance and cleaning
 Personnel matters:
oQualification
oTraining
oClothing
oHygiene
Which activities require
SOPs?
Environmental
monitoring Pest
control
Complaints
Recalls
Returned
goods
SOP and records for receiving materials
 Name of material as on delivery note
 Name and in-house code
 Date of receipt
 Supplier's and manufacturer's name
 Batch number
 Quantity and number of containers received
 State of container and other information
Other SOPs include:
 Internal labelling, quarantine and storage of
materials
 Operation, maintenance, calibration and cleaning
of all instruments and equipment – production and
QC
 Sampling of materials
 Batch numbering systems
 Material testing at all stages of production
 Complaints, recalls
Which activities require SOPs?
(Continued)
 Batch release or rejection
 Maintenance of distribution records
 Equipment assembly and validation
 Maintenance, cleaning and sanitation
 Personnel recruitment, training, clothing and
hygiene
…and many more…
Stock Control and Distribution Records
What should be recorded?
Where should records be
stored? Why are the records
important?
Data Integrity a Hot Topic in EU and
US
 FDA - Draft guidance on Data integrity and
Compliance
with cGMP issued April 16
 MHRA - Draft guidance on GXP Data Integrity
Definitions and Guidance for Industry July 16
 PIC/S – Draft guidance on Good practices for
Data Management and Integrity in Regulated
GMP/GXP Environments Aug 16
 EMA extended the Q and A section of the GMP
webpage with an additional 23 questions and
answers regarding Data Integrity
6.1 Documentation.pptxxxxxxxxxxxxxxxxxxx
• Data integrity enables good decision-making by pharmaceutical
manufacturers and regulatory authorities
• It is a fundamental requirement of the pharmaceutical quality system
described in EU GMP chapter 1, applying equally to manual (paper) and
electronic systems.
• Promotion of a quality culture together with implementation of
organisational and technical measures which ensure data integrity is
the responsibility of senior management.
• It requires participation and commitment by staff at all levels
within the company, by the company’s suppliers and by its
distributors.
• Senior management should ensure that data integrity risk is assessed,
mitigated and communicated in accordance with the principles of
quality risk management.
• The importance of data integrity to quality assurance and public
health protection should be included in personnel training
programmes.
Data Integrity – a foundational requirement
• The template (blank) forms used for manual recordings
may be created in an electronic system (Word, Excel, etc.).
• The corresponding master documents should be approved
and controlled electronically or in paper versions.
• The following expectations should be considered for the
template (blank) form:
 have a unique reference number (including version number)
and include reference to corresponding SOP number
 should be stored in a manner which ensures appropriate
version control
 if signed electronically, should use a secure e-signature
• The distribution of template records (e.g. ‘blank’ forms) should
be
controlled.
• The following expectations should be considered where
appropriate, based on data risk and criticality:
 enable traceability for issuance of the blank form by using a
bound
logbook with numbered pages or other appropriate system.
 For loose leaf template forms, the distribution date, a
sequential issuing number, the number of the copies
distributed, the department name where the blank forms

More Related Content

PPTX
Technology transfer from Research and development to production
PPT
Scigmoid Publications
PPTX
Documentation
PPTX
Good manufacturing practices (gmp) Akash Saini (Dr. H. S. Gour University, Sa...
PPT
P rocess validation 1
DOCX
Appendix 3 Deligence checklist
PPTX
Documentation
PPTX
Documentation In Pharmaceutical Industry.pptx
Technology transfer from Research and development to production
Scigmoid Publications
Documentation
Good manufacturing practices (gmp) Akash Saini (Dr. H. S. Gour University, Sa...
P rocess validation 1
Appendix 3 Deligence checklist
Documentation
Documentation In Pharmaceutical Industry.pptx

Similar to 6.1 Documentation.pptxxxxxxxxxxxxxxxxxxx (20)

PPTX
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
PPTX
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
PPTX
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
PPTX
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
PPTX
2.0 qualityassuranceandregulatorycomplianceforpharmaceuticalproduct
PPTX
Quality control and quality assurance.pptx
PPTX
QUALITY DOCCUMENTATION 060.pptx
PPT
Validation Theory And Application 3
PPT
Good Manufacturing Practices For Quality Control
DOCX
Tiêu chuẩn GMP EU chương 4. Tiêu chí về hệ thống Tài liệu
PPSX
GMP documentation
PPTX
Manufacturing documents-GMP
PPTX
Documentation control - principles of GMP
PPTX
TLE.ppt. ICT. Automotive. Smaw. all about technology livelihood
PPTX
Pharmaceutical Documentation
PPTX
1.Documentation in Pharmaceutical Industry.pptx
PPT
Process validation
PDF
Good Documents Practice PDF BY SMD.pdf
PDF
Good Documents Practice PDF BY SMD.pdf
PPTX
PRESENTATION QA Lucky Udit.pptx document maintenance in pharmacheutical industry
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct
Quality assuranceandregulatorycomplianceforpharmaceuticalproduct(4)
2.0 qualityassuranceandregulatorycomplianceforpharmaceuticalproduct
Quality control and quality assurance.pptx
QUALITY DOCCUMENTATION 060.pptx
Validation Theory And Application 3
Good Manufacturing Practices For Quality Control
Tiêu chuẩn GMP EU chương 4. Tiêu chí về hệ thống Tài liệu
GMP documentation
Manufacturing documents-GMP
Documentation control - principles of GMP
TLE.ppt. ICT. Automotive. Smaw. all about technology livelihood
Pharmaceutical Documentation
1.Documentation in Pharmaceutical Industry.pptx
Process validation
Good Documents Practice PDF BY SMD.pdf
Good Documents Practice PDF BY SMD.pdf
PRESENTATION QA Lucky Udit.pptx document maintenance in pharmacheutical industry
Ad

Recently uploaded (20)

PDF
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
PDF
Medical Evidence in the Criminal Justice Delivery System in.pdf
PPT
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
PPT
ASRH Presentation for students and teachers 2770633.ppt
PPT
Breast Cancer management for medicsl student.ppt
PPT
MENTAL HEALTH - NOTES.ppt for nursing students
DOCX
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
PPTX
CME 2 Acute Chest Pain preentation for education
PPTX
Important Obstetric Emergency that must be recognised
PPTX
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
PPTX
ACID BASE management, base deficit correction
PPT
Obstructive sleep apnea in orthodontics treatment
PPTX
Fundamentals of human energy transfer .pptx
PPTX
Gastroschisis- Clinical Overview 18112311
PDF
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
PPTX
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
PPTX
neonatal infection(7392992y282939y5.pptx
PDF
Human Health And Disease hggyutgghg .pdf
PPTX
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
PPTX
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Therapeutic Potential of Citrus Flavonoids in Metabolic Inflammation and Ins...
Medical Evidence in the Criminal Justice Delivery System in.pdf
genitourinary-cancers_1.ppt Nursing care of clients with GU cancer
ASRH Presentation for students and teachers 2770633.ppt
Breast Cancer management for medicsl student.ppt
MENTAL HEALTH - NOTES.ppt for nursing students
RUHS II MBBS Microbiology Paper-II with Answer Key | 6th August 2025 (New Sch...
CME 2 Acute Chest Pain preentation for education
Important Obstetric Emergency that must be recognised
15.MENINGITIS AND ENCEPHALITIS-elias.pptx
ACID BASE management, base deficit correction
Obstructive sleep apnea in orthodontics treatment
Fundamentals of human energy transfer .pptx
Gastroschisis- Clinical Overview 18112311
Handout_ NURS 220 Topic 10-Abnormal Pregnancy.pdf
Electromyography (EMG) in Physiotherapy: Principles, Procedure & Clinical App...
neonatal infection(7392992y282939y5.pptx
Human Health And Disease hggyutgghg .pdf
CEREBROVASCULAR DISORDER.POWERPOINT PRESENTATIONx
Chapter-1-The-Human-Body-Orientation-Edited-55-slides.pptx
Ad

6.1 Documentation.pptxxxxxxxxxxxxxxxxxxx

  • 2. 1. To review general requirements for documents 2. To review specific requirements for each document 3. To consider current issues applicable to a facility
  • 3. Good documentation is an essential part of the QA system Should exist for all aspects of GMP Purpose of documentation  Defines specifications and procedures for all materials and methods of manufacture and control  Ensures all personnel know what to do and when to do it  Ensures that authorized persons have all information necessary for release of product
  • 4. Purpose of documentation (cont.)  Ensures documented evidence, traceability and provides records and audit trail for investigation  Ensures availability of data for validation, review and statistical analysis Design and use  Depends upon manufacturer  Some documents combined into one, sometimes separate
  • 5. Documents should be  Designed  Prepared  Reviewed  Distributed with care Carefully controlled Comply with Marketing Authorization
  • 6. Design of documentation important Look at the “Style” of the document  Instructions in the imperative  Short sentences preferred to long sentences Approval of documentation  Approved, signed and dated by appropriate responsible persons  No document should be changed without authorization and approval
  • 7. Contents of documents should be clear (easy to understand) and include, e.g.  Title, nature, objective or purpose Layout in orderly fashion Easy to be filled in and checked Clear and readable – including copies made No errors if master documents are copied for working documents
  • 8. Documentation control Regular review of documents Kept up to date (current) - amended Superseded documents removed and not used  Distribution and retrieval of documentation Retention time for superseded documents
  • 9. Data entry Clear, readable and indelible Design to allow for sufficient space for entries Changes to entries:  signed, dated and reason given  original entry still readable Entries at the time of action All significant actions recorded – traceable
  • 10. Data entry (cont.) Electronic data processing systems, photographic systems or other reliable means  Systems require SOPs and records  Accuracy of records checked  Authorized persons - access and changes  Password controlled  Entries checked
  • 11. Data entry (cont.) Batch records stored electronically:  Protected  Back-up transfer, e.g. magnetic tape, microfilm, paper print-outs Records kept 1 year after expiry date of product Data readily available during retention period
  • 12. Labels Specifications and testing procedures Master formulae and instructions Batch processing and batch packaging records Standard Operating Procedures (SOPs) Records  Stock control and distribution records Other documents …
  • 13. Photographs can be documents provided they are properly authorised and controlled
  • 14. Flow charts provide substantial information at a glance
  • 15. What must be labelled? • Containers, equipment, premises • Intermediates and bulk products Label information? •Clear, unambiguous, company format Colours can be used, e.g. green (accepted), red (rejected)
  • 16. Different types of labels, e.g. cleaning status, production stage, status of materials Other types of labels?
  • 17. Labels can indicate the status of materials such as "quarantine"
  • 18. National legislation, but includes: Name Active ingredients and amounts Batch number Expiry date Storage conditions, precautions if necessary Directions for use, warnings Name and address of manufacturer
  • 19. Label to include: Name Potency or concentration Date of manufacture Expiry date Date the closure is first opened Storage condition Control number
  • 20. Authorized, approved, signed and dated  Starting, packaging materials and finished products: include tests on identity, content, purity, quality  Intermediates and bulk  Water, solvents and reagents QC, QA or documentation centre
  • 21. • Documented Specifications Are required for • Starting and packaging materials • Finished products
  • 22. Specifications: Periodic review Compliance with current pharmacopoeia Pharmacopoeia, reference standards and spectra available Test Procedures: Validated (facility and equipment) before routinely used
  • 23. Master formula for each product and batch size Manufacturing instructions include:  Name of product with product reference code  Dosage form, strength and batch size  List of starting materials including quantities and unique reference code  Expected final yield with acceptable limits (and intermediate yields)  Processing location and principal equipment
  • 24. Manufacturing instructions – continued  Equipment preparation (e.g. cleaning, assembling, calibrating, etc.)  Detailed stepwise processing instructions and checks, pre-treatments, sequence of additions, times, temperatures, etc.  In-process control instructions and their limits  Storage requirements and special precautions  Any special precautions if needed
  • 25. Authorized packing instructions for each product, pack size and type, and to include:  Name of the product  Dosage form, strength and method of application  Pack size (number, weight or volume of product in final container)  List of all packaging materials (quantities, size, types and code number)
  • 26. Packing instructions – continued  Examples of printed packaging materials, with location of batching information  Special precautions, including area clearance checks (before and after operations)  Description of the packaging operation including equipment to be used  In-process controls, with sampling instructions and acceptance limits
  • 27. Record kept for each batch processed Based on the master or specifications (e.g. copied to avoid errors) Check suitability of area and equipment  clear of previous products, documents, materials Checks recorded
  • 28. Information recorded during processing include: Name of the product, batch number Dates and times (e.g. start, major steps, completion) Name of person responsible for each stage of production Name of operators carrying out each step (check signatures) Theoretical quantities for materials in the batch Reference number and quantity of materials used in the batch
  • 29. Main processing steps and key equipment In-process controls carried out, person's initials, and results obtained Yield at each stage with comments on deviations Expected final yield with acceptable limits Comments on any deviations from process Area clearance check, instructions to operators Record of activities
  • 30. For every batch or part of a batch Based on approved packaging instructions, copied or computer generated Before start – checks that equipment and work station suitable and clean, no previous product Line clearance (opening) Recorded
  • 31. Name of the product, batch number and quantity to be packed Batch number, theoretical quantity and actual quantity of finished product Actual quantity obtained – reconciliation Dates and times of operation Name of person responsible for packaging, initials of operators carrying out each step Checks, and in-process results
  • 32. Details of packaging operation, including equipment and line used Returns to store Specimen of printed packaging materials, with batch coding approval (batch number and expiry date) Comments on deviations from the process and actions taken and authorization Reconciliation of packaging materials, including issues, use, returns and destruction
  • 33. What is an SOP? Who is responsible for preparing SOPs? What is the format for an SOP? Which activities require SOPs? Where should SOPs be stored? Are SOPs associated with records?
  • 34. Which activities require SOPs? Equipment and analytical apparatus: – Assembly, validation – Calibration – Internal labelling, quarantine and storage of materials – Operation – Maintenance and cleaning  Personnel matters: oQualification oTraining oClothing oHygiene
  • 35. Which activities require SOPs? Environmental monitoring Pest control Complaints Recalls Returned goods
  • 36. SOP and records for receiving materials  Name of material as on delivery note  Name and in-house code  Date of receipt  Supplier's and manufacturer's name  Batch number  Quantity and number of containers received  State of container and other information
  • 37. Other SOPs include:  Internal labelling, quarantine and storage of materials  Operation, maintenance, calibration and cleaning of all instruments and equipment – production and QC  Sampling of materials  Batch numbering systems  Material testing at all stages of production  Complaints, recalls
  • 38. Which activities require SOPs? (Continued)  Batch release or rejection  Maintenance of distribution records  Equipment assembly and validation  Maintenance, cleaning and sanitation  Personnel recruitment, training, clothing and hygiene …and many more…
  • 39. Stock Control and Distribution Records What should be recorded? Where should records be stored? Why are the records important?
  • 40. Data Integrity a Hot Topic in EU and US  FDA - Draft guidance on Data integrity and Compliance with cGMP issued April 16  MHRA - Draft guidance on GXP Data Integrity Definitions and Guidance for Industry July 16  PIC/S – Draft guidance on Good practices for Data Management and Integrity in Regulated GMP/GXP Environments Aug 16  EMA extended the Q and A section of the GMP webpage with an additional 23 questions and answers regarding Data Integrity
  • 42. • Data integrity enables good decision-making by pharmaceutical manufacturers and regulatory authorities • It is a fundamental requirement of the pharmaceutical quality system described in EU GMP chapter 1, applying equally to manual (paper) and electronic systems. • Promotion of a quality culture together with implementation of organisational and technical measures which ensure data integrity is the responsibility of senior management. • It requires participation and commitment by staff at all levels within the company, by the company’s suppliers and by its distributors. • Senior management should ensure that data integrity risk is assessed, mitigated and communicated in accordance with the principles of quality risk management. • The importance of data integrity to quality assurance and public health protection should be included in personnel training programmes. Data Integrity – a foundational requirement
  • 43. • The template (blank) forms used for manual recordings may be created in an electronic system (Word, Excel, etc.). • The corresponding master documents should be approved and controlled electronically or in paper versions. • The following expectations should be considered for the template (blank) form:  have a unique reference number (including version number) and include reference to corresponding SOP number  should be stored in a manner which ensures appropriate version control  if signed electronically, should use a secure e-signature • The distribution of template records (e.g. ‘blank’ forms) should be controlled. • The following expectations should be considered where appropriate, based on data risk and criticality:  enable traceability for issuance of the blank form by using a bound logbook with numbered pages or other appropriate system.  For loose leaf template forms, the distribution date, a sequential issuing number, the number of the copies distributed, the department name where the blank forms